REGENEUS LTD (ASX:RGS)
Industry: Classification Pending
Activity: Regenerative medicine.
25 Bridge Street PYMBLE NSW 2073
Ph: (02) 9499 8010    Fax: (02) 9499 8020
Duncan Thomson
Wed, 13 Nov 2013 1:30pm
Duncan Thomson, Head of Animal Health
Icon_lastIcon_nextIcon_previousIcon_first
Interim Results
Thu, 19 Feb 2015
Annual General Meeting
Tue, 28 Oct 2014
Full Year Results
Mon, 25 Aug 2014
Interim Results
Thu, 27 Feb 2014
Annual General Meeting
Wed, 27 Nov 2013
New Director joins Regeneus Board of Directors Mon, 23 Feb 2015
Regeneus Half-Yearly Appendix 4D and Accounts Thu, 19 Feb 2015
Regeneus Half-Year Announcement Thu, 19 Feb 2015
Appendix 4C - Q2 FY15 Fri, 30 Jan 2015
Patent granted for protecting cryopreserved stem cells Fri, 19 Dec 2014
New Japanese laws to fast track cell therapy take effect Wed, 26 Nov 2014
Regeneus concludes strategic review Mon, 24 Nov 2014
Acne treatment patent granted Fri, 14 Nov 2014
Board and Management Changes Mon, 10 Nov 2014
Subscription for shares and options by Directors Thu, 6 Nov 2014

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.